Neu-Ulm

• A study to learn about how different drugs interact with each drug in a new 7-drug mixture as they move into, through, and out of the body i … Pending
  2023-504870-39-00 3 drug-drug interactions (DDI)
• Relative bioavailability and safety study of pasireotide after a single-dose subcutaneous administration in the arm or in the thigh compared … Pending
  2025-521830-27-00 3 Post-bariatric hypoglycaemia
• Study in healthy volunteers to compare the blood levels after epoetin alfa (Blau EPO) and Erypo, administered as a single intravenous inject … Pending
  2025-522244-40-00 3 It is used to treat symptomatic anaemia in chronic renal failure
• Study in healthy male participants to compare the blood levels after epoetin alfa (Blau EPO) and Erypo, administered as multiple intravenous … Pending
  2025-522246-43-00 3 Treatment of symptomatic anemia associated with chronic renal failure:
• A study to learn about the amount of asundexian in the blood and the effect of food on its levels when healthy participants take it as adult … Recruiting
  2025-523677-41-00 3 2026-05-06 Prevention of thromboembolic events
• Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy Participants Recruiting
  2024-513069-37-00 1 2026-01-30 Healthy
• A first-in-human study to learn about how safe BAY 3620122 is, how much of it gets absorbed in the blood, and how it affects the body of hea … Recruiting
  2025-523301-15-00 1 2025-12-17 Vasodilatory shock
• A Phase I/II, Randomised, Single-blind, Placebo-controlled, Multiple-ascending-dose Study to Evaluate the Safety, Tolerability, Pharmacokine … Ended recruitment
  2023-504215-32-00 9 2023-09-28 Overweight and obesity
• A prospective, multicentre, randomised, double-dummy, double-blind, placebo-controlled 3-way Phase III study to investigate the efficacy and … Halted
  2022-502903-31-00 5 2025-11-05 Patients with ADHD (according to ICD-10 / DSM-5)
• Crossover study to investigate the safety and tolerability as well as the blood levels after three single doses of Tacrolimus, of which 2 ar … Ended
  2025-525076-29-00 3 2026-03-23 Phase I study in healthy male volunteers. Intended indication: prophyl
• A study to find out whether the medication pasireotide is absorbed and processed the same way when given under the skin using either a reusa … Ended
  2024-519165-22-00 3 2025-11-04 Post-bariatric hypoglycaemia
• A Phase 1 Randomized, Placebo-Controlled, Double-Blind Study of the Safety, Tolerability and Pharmacological Effects of PT00114 in Healthy V … Ended
  2024-519316-13-00 1 2025-08-01 Phase I study in healthy male and female volunteers. Intended indicati
• A first-in-human study to learn about how safe the study drug is in healthy participants Ended
  2024-517512-30-00 1 2025-04-28 Cardiac arrhythmia
• A study to learn about how itraconazole affects the level of emodepside in the blood when emodepside is given as a new type of tablet to hea … Ended
  2024-515757-24-00 3 2025-02-04 Soil-transmitted helminth infection
• A Phase 1, multiple-dose, single-center, randomized, open-label, 2-period, 2-treatment crossover systemic bioavailability study of diclofena … Ended
  2024-515954-26-00 3 2024-11-19 Phase I Study in healthy male and female volunteers. Intended indicati
• A TQT Study to Investigate the Effect of Enpatoran on Cardiac Repolarization in Healthy Participants Ended
  2024-512841-17-00 3 2024-09-04 Healthy
• Evaluation of vamorolone CYP3A4 induction on midazolam (a sensitive CYP3A4 substrate) pharmacokinetics Ended
  2024-513845-36-00 3 2024-08-13 Phase I study in healthy male volunteers. Intended indication: Duchenn
• A study to learn how asundexian affects the amount of metformin in the blood when healthy participants take them together Ended
  2023-509488-26-00 3 2024-07-18 Prevention of ischemic stroke in patients after an acute non-cardioemb
• A study to learn how vamorolone affects the body, how safe it is and how it moves into, through and out of the body in healthy male particip … Ended
  2024-512101-60-00 3 2024-06-05 Phase I study in healthy male volunteers. Intended indication: Duchenn
• A study to learn about how much emodepside gets absorbed in the blood and how food affects its absorption when given as a new type of tablet … Ended
  2023-508905-26-00 3 2024-05-06 Onchocerciasis (river blindness): is an infectious disease caused by O
• A study to learn how much elinzanetant gets into the blood, how safe it is and how it affects the body after taking single and multiple amou … Ended
  2023-503864-17-00 3 2023-09-20 Vasomotor Symptoms as a sex hormone-dependent disorder in women and me
• A study to learn how safe the study treatment BAY2701250 is, how it affects the body and how it moves into, through and out of the body in h … Ended
  2023-503368-18-00 1 2023-09-14 Pulmonary hypertension due to left heart disease
• A first in human single dose escalation study to investigate the safety, tolerability, pharmacokinetics, and pharmcodynamics of BAY 3389934 … Ended
  2022-502866-25-00 1 2023-08-18 Sepsis associated disseminated intravascular coagulation
• A two-part, open-label study to assess the pharmacokinetics, pharmacodynamics and safety of single doses of inhaled and intravenously admini … Ended
  2022-503037-63-00 3 2023-08-17 Phase I, Clinical trial in healthy males and females intended indicati

Showing 1–24 of 25 trials